News Minimalist logo

Oral spray vaccine prevents recurring UTIs for up to 9 years

The Telegraph — April 7, 2024, 02:00 AM UTC

Summary: A British trial showed an oral spray vaccine can prevent recurring UTIs for up to nine years, benefiting those facing 150,000 annual hospitalizations costing the NHS £380 million. Half of women and 20% of men suffer from UTIs, with a death rate of 6,000 annually. The vaccine, Uromune, led to 48% remaining infection-free for nine years, with an average infection-free period of 54.7 months.

Full article

Article metrics
Significance6.6
Scale8.0
Magnitude7.5
Potential8.5
Novelty7.0
Actionability6.0
Immediacy9.0
Positivity8.0
Credibility9.0

Timeline:

  1. [5.3]
    Oral spray vaccine prevents UTIs for up to 9 years (ABC News)
    23d

    ScoresSource
  2. [4.6]
    MV140 oral spray vaccine for UTI shows long-term efficacy (Onmanorama)
    26d
    Summary:Source
  3. [5.3]
    Oral spray vaccine MV140 prevents recurrent UTIs for years (Connected to India)
    26d

    ScoresSource
  4. [5.1]
    Oral spray vaccine prevents UTIs for up to 9 years (The Independent)
    26d

    ScoresSource
  5. [4.2]
    Uromune vaccine shows promise in preventing recurring UTIs long-term (The Mirror)
    27d
    Summary:Source
  6. [6.2]
    Oral spray vaccine MV140 prevents recurrent UTIs long-term (Cosmos)
    27d

    ScoresSource